Publications
Publications 4826 - 4850 de 33557
Titre | DOI |
---|---|
BURR FORMATION AT THE INTERFACE DURING BI-MATERIAL ORTHOGONAL CUTTING C. Poissenot-Arrigoni; G. Fromentin; G. Poulachon; B. Marcon; C. Legrand 2021 |
10.17973/MMSJ.2021_11_2021161 |
Business Constraints Integration in a Search Engine Optimization Fuzzy Decision Support System S. Sagot; A.J. Fougeres; E. Ostrosi 2017 |
10.1109/CBI.2017.61 |
Business cycle prediction: Application of Markov chain to online crowdlending S. Krishnan; A. Ashta; D. Babu 2021 |
10.1002/jsc.2428 |
Buttock abscess: A late complication of prosthetic surgery for stress urinary incontinence S. Mazellier; M. Lallemant; A.S. Tholozan; J.J. Terzibachian; R. Ramanah 2020 |
10.1016/j.gofs.2020.02.010 |
Bypassing the central bottleneck with easy tasks: Beyond ideomotor compatibility M. Lyphout-Spitz; F. Maquestiaux; E. Ruthruff Submitted |
10.3758/s13423-021-01974-1 |
C-12/C-13 isotopic ratios in red-giant stars of the open cluster NGC 6791 L. Szigeti; S. Meszaros; V.V. Smith; K. Cunha; N. Lagarde; C. Charbonnel; D.A. Garcia-Hernandez; M. Shetrone; M. Pinsonneault; C.Allende Prieto; J.G. Fernandez-Trincado; J. Kovacs; S. Villanova 2018 |
10.1093/mnras/stx3027 |
C-4 grass functional traits are correlated with biotic and abiotic gradients in an African savanna Y. Bouchenak-Khelladi; E.C. February; G.A. Verboom; F.C. Boucher 2020 |
10.1007/s11258-020-01007-2 |
C-H Bond Arylation of Pyrazoles at the beta-Position: General Conditions and Computational Elucidation for a High Regioselectivity X. Shi; D.Sosa Carrizo; M. Cordier; J. Roger; N. Pirio; J.C. Hierso; P. Fleurat-Lessard; J.F. Soule; H. Doucet 2021 |
10.1002/chem.202100031 |
C-H Halogenation of Pyridyl Sulfides Avoiding the Sulfur Oxidation: A Direct Catalytic Access to Sulfanyl Polyhalides and Polyaromatics J. Guilbaud; S. Awatef; M. Kammoun; S. Contal; C. Montalbetti; N. Pirio; J. Roger; J.C. Hierso 2019 |
10.1021/acsomega.9b01636 |
C-k-SMOOTH APPROXIMATIONS OF LUR NORMS P. Hajek; A. Prochazka 2014 |
|
C-k-SMOOTH APPROXIMATIONS OF LUR NORMS P. Hajek; A. Prochazka 2014 |
|
c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma A. Bouroumeau; L. Bussot; T. Bonnefoix; C. Fournier; C. Chapusot; O. Casasnovas; L. Martin; A. McLeer; E. Col; L. David-Boudet; C. Lefebvre; C. Algrin; T. Raskovalova; M.C. Jacob; C. Vettier; S. Chevalier; M.B. Callanan; R. Gressin; A. Emadali; H. Sartelet 2021 |
10.1002/cjp2.223 |
C-PRECISE-01 study: A phase Ib/II trial of MEN1611, a PI3K inhibitor, and cetuximab in patients with PIK3CA mutated metastatic colorectal cancer failing irinotecan, oxaliplatin, 5-FU and anti-EGFR containing regimens J. Tabernero; E. Fernandez; F. Ghiringhelli; G. Folprecht; G. Curigliano; S. Siena; C. Cremolini; A. Sobrero; M. Kwiatek; R. Keranen; D. Ahn; C. Punt; D. Laurent; M. Ferrara; A. Pellacani; A. Capriati 2020 |
10.1016/j.annonc.2020.04.161 |
C-reactive protein to rule out infections after major abdominal surgery P. Ortega-Deballon; O. Facy; P. Rat 2016 |
10.1007/s00384-015-2283-x |
C-terminal amino acids are essential for human heat shock protein 70 dimerization G. Marcion; R. Seigneuric; E. Chavanne; Y. Artur; L. Briand; T. Hadi; J. Gobbo; C. Garrido; F. Neiers 2015 |
10.1007/s12192-014-0526-3 |
C1 fracture: Analysis of consolidation and complications rates in a prospective multicenter series M. Lleu; Y.Philippe Charles; B. Blondel; L. Barresi; B. Nicot; V. Challier; J. Godard; P. Kouyoumdjian; N. Lonjon; P. Marinho; E. Freitas; S. Schuller; S. Fuentes; J. Allia; J. Berthiller; C. Barrey 2018 |
10.1016/j.otsr.2018.06.014 |
C3 nephritic factor associated with C3 glomerulopathy in children C. Nicolas; V. Vuiblet; V. Baudouin; M.A. Macher; I. Vrillon; N. Biebuyck-Gouge; M. Dehennault; S. Gie; D. Morin; H. Nivet; F. Nobili; T. Ulinski; B. Ranchin; M.Chiarra Marinozzi; S. Ngo; V. Fremeaux-Bacchi; C. Pietrement 2014 |
10.1007/s00467-013-2605-6 |
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies M.C. Marinozzi; S. Chauvet; M. Le Quintrec; M. Mignotet; F. Petitprez; C. Legendre; M. Cailliez; G. Deschenes; M. Fischbach; A. Karras; F. Nobili; C. Pietrement; M.A. Dragon-Durey; F. Fakhouri; L.T. Roumenina; V. Fremeaux-Bacchi 2017 |
10.1016/j.kint.2017.04.017 |
C5orf42 is the major gene responsible for OFD syndrome type VI E. Lopez; C. Thauvin-Robinet; B. Reversade; N.El Khartoufi; L. Devisme; M. Holder; H. Ansart-Franquet; M. Avila; D. Lacombe; P. Kleinfinger; I. Kaori; J.I. Takanashi; M. Le Merrer; J. Martinovic; C. Noel; M. Shboul; L. Ho; Y. Guven; F. Razavi; L. Burglen; N. Gigot; V. Darmency-Stamboul; J. Thevenon; B. Aral; H. Kayserili; F. Huet; S. Lyonnet; C. Le Caignec; B. Franco; J.B. Riviere; L. Faivre; T. Attie-Bitach 2014 |
10.1007/s00439-013-1385-1 |
C60 molecules grown on a Si-supported nanoporous supramolecular network: a DFT study K. Boukari; E. Duverger; R. Stephan; M.C. Hanf; P. Sonnet 2014 |
10.1039/c4cp01677g |
CA 125 assay in the extension assessment of newly diagnosed breast cancers: why and how? A. Laffont; V. Goussot; A. Berriolo-Riedinger; J.M. Riedingr 2018 |
10.1684/abc.2018.1368 |
CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients N. Santucci; O. Facy; P. Ortega-Deballon; J.B. Lequeu; P. Rat; P. Rat 2018 |
10.1016/j.pan.2018.07.001 |
Ca2+ signaling in taste bud cells and spontaneous preference for fat: Unresolved roles of CD36 and GPR120 S. Abdoul-Azize; S. Selvakumar; H. Sadou; P. Besnard; N.Akhtar Khan 2014 |
10.1016/j.biochi.2013.06.005 |
Cabazitaxel (CBZ) activity in men with metastatic castration resistant prostate cancer (mCRPC) with and without DNA damage repair (DDR) defects M. Aldea; L. Lam; L. Perez; M. Saint-Ghislain; G. Mescam; A. Flechon; G. Roubaud; P. Barthelemy; F. Ricci; F. Priou; Z.M. Neviere; M. Beaufils; C. Helissey; R. Ratta; C. Pobel; C. Marcos; A. Thiery-Vuillemin; G. Baciarello; E. Orillard; K. Fizazi 2020 |
10.1016/j.annonc.2020.08.873 |
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA S. Oudard; K. Fizazi; L. Sengelov; G. Daugaard; F. Saad; S. Hansen; M. Hjalm-Eriksson; J. Jassem; A. Thiery-Vuillemin; O. Caffo; D. Castellano; P.N. Mainwaring; J. Bernard; L. Shen; M. Chadjaa; O. Sartor 2017 |
10.1200/JCO.2016.72.1068 |